Clinical trial
Identifying Genetic Variants in Nicotinamide Adenine Dinucleotide (NAD) Synthesis Pathway in Patients With Congenital Malformations
NCT03799705 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Identifying Genetic Variants in Nicotinamide Adenine Dinucleotide (NAD) Synthesis Pathway in Patients With Congenital Malformations
- Lead sponsor
- Mayo Clinic
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 1, 2019
- Completion date
- December 1, 2022
- Enrollment
- 132 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
congenital malformation, vacterl association